Despite these prior studies, the molecular mechanism by which mGluR7 achieves its physiological functions and whether activation of mGluR7 can be a potential therapeutic approach for neurodevelopmental disorders, such as FXS, remains unclear. This evidence concerns the gene GRM7 and neurodevelopmental disorder.